| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.072 | 0.01 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.02 |